accountin Hong Kong. Shanghai Pharmaceuticals, China's largest listed drug maker by revenue, plans to seek approval from the Hong Kong stock exchange Thursday to list in May, a person familiar with the situation said Wednesday. The Shanghai-listed company said...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to Regulator Clears Shanghai Pharma IPO Plan
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account